(Q38045223)

27 August 2017

title

Neurodegeneration, β-amyloid and mood disorders: state of the art and future perspectives (English)

1 reference

27 August 2017

1 reference

1 reference

Armando Piccinni

1

0 references

Luciano Domenici

object named as

Luciano Domenici

series ordinal

8

0 references

Donatella Marazziti

object named as

Donatella Marazziti

series ordinal

5

0 references

Liliana Dell'Osso

series ordinal

9

object named as

Liliana Dell'Osso

1 reference

27 August 2017

3

Antonello Veltri

1 reference

27 August 2017

4

Chiara Vizzaccaro

1 reference

27 August 2017

6

Federica Vanelli

1 reference

27 August 2017

7

Ilenia Moroni

1 reference

27 August 2017

Nicola Origlia

2

1 reference

27 August 2017

language of work or name

English

0 references

publication date

20 September 2012

1 reference

International Journal of Geriatric Psychiatry

27 August 2017

published in

1 reference

27 August 2017

volume

28

1 reference

27 August 2017

issue

7

1 reference

27 August 2017

page(s)

661-671

1 reference

Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP/PS1 transgenic mice.

27 August 2017

cites work

1 reference

An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia

21 January 2018

1 reference

Depression and the risk of Alzheimer disease.

21 January 2018

1 reference

Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats

21 January 2018

1 reference

Neurotrophins, synaptic plasticity and dementia

21 January 2018

1 reference

Metabolism of amyloid-β protein may be affected in depression

21 January 2018

1 reference

Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia

21 January 2018

1 reference

New views on antidepressant action

21 January 2018

1 reference

Plasma Amyloid Beta-42 Independently Predicts Both Late-Onset Depression and Alzheimer Disease

21 January 2018

1 reference

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

Spatial learning and the saturation of long-term potentiation

21 January 2018

1 reference

Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study

21 January 2018

1 reference

The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients.

21 January 2018

1 reference

Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-ß production.

21 January 2018

1 reference

Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer's disease.

21 January 2018

1 reference

Depression predicts cognitive disorders in older primary care patients.

21 January 2018

1 reference

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory

21 January 2018

1 reference

Cognitive function in the affective disorders: a prospective study.

21 January 2018

1 reference

Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice.

21 January 2018

1 reference

Release of beta-amyloid from high-density platelets: implications for Alzheimer's disease pathology

21 January 2018

1 reference

Neurotrophic effects of antidepressant drugs

21 January 2018

1 reference

Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus

21 January 2018

1 reference

The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials

21 January 2018

1 reference

Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.

21 January 2018

1 reference

Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo

21 January 2018

1 reference

Soluble beta amyloid(1-42): a critical player in producing behavioural and biochemical changes evoking depressive-related state?

21 January 2018

1 reference

Hippocampal volume reduction and HPA-system activity in major depression

21 January 2018

1 reference

Does depression precede or follow executive dysfunction? Outcomes in older primary care patients

21 January 2018

1 reference

Altered empathic responding in major depressive disorder: relation to symptom severity, illness burden, and psychosocial outcome

21 January 2018

1 reference

Hypothalamic-pituitary-adrenal axis and bipolar disorder.

21 January 2018

1 reference

Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine

21 January 2018

1 reference

Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease

21 January 2018

1 reference

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

21 January 2018

1 reference

LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

21 January 2018

1 reference

Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease

21 January 2018

1 reference

Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons.

21 January 2018

1 reference

Associations between brain-derived neurotrophic factor plasma levels and severity of the illness, recurrence and symptoms in depressed patients

21 January 2018

1 reference

Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers

21 January 2018

1 reference

Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community

21 January 2018

1 reference

Correlations of synaptic and pathological markers with cognition of the elderly

21 January 2018

1 reference

Plasma amyloid beta, apolipoprotein E, lacunar infarcts, and white matter lesions

21 January 2018

1 reference

RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease

21 January 2018

1 reference

Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment.

21 January 2018

1 reference

Role of neurotrophic factors in the etiology and treatment of mood disorders

21 January 2018

1 reference

21 January 2018

1 reference

Neuropsychological function in euthymic patients with bipolar disorder.

21 January 2018

1 reference

Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels

21 January 2018

1 reference

History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease.

21 January 2018

1 reference

Common mechanisms of amyloid oligomer pathogenesis in degenerative disease

21 January 2018

1 reference

The neurocognitive signature of psychotic bipolar disorder

21 January 2018

1 reference

Effects of β-amyloid protein on serotoninergic, noradrenergic, and cholinergic markers in neurons of the pontomesencephalic tegmentum in the rat

21 January 2018

1 reference

Toxic effects of depression on brain function: impairment of delayed recall and the cumulative length of depressive disorder in a large sample of depressed outpatients

21 January 2018

1 reference

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

21 January 2018

1 reference

Depression as a risk factor for Alzheimer disease: the MIRAGE Study

21 January 2018

1 reference

21 January 2018

1 reference

The relationship between cerebrospinal fluid biomarkers and depression in elderly women

21 January 2018

1 reference

Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.

21 January 2018

1 reference

Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity.

21 January 2018

1 reference

AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss

21 January 2018

1 reference

Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group

21 January 2018

1 reference

Allostatic load in bipolar disorder: implications for pathophysiology and treatment

21 January 2018

1 reference

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

21 January 2018

1 reference

Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?

21 January 2018

1 reference

Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses

21 January 2018

1 reference

Lithium treatment and risk of dementia.

21 January 2018

1 reference

Do continued antidepressants protect against dementia in patients with severe depressive disorder?

21 January 2018

1 reference

Apolipoprotein e4 genotype and depressive symptoms as risk factors for dementia in an older korean population

21 January 2018

1 reference

Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.

21 January 2018

1 reference

Depressive symptoms and cognitive decline in community-dwelling older adults.

21 January 2018

1 reference

Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor

21 January 2018

1 reference

Cerebrospinal Fluid Alzheimer Markers in Depressed Elderly Subjects with and without Alzheimer's Disease

21 January 2018

1 reference

The molecular neurobiology of depression

21 January 2018

1 reference

Beyond monoamines: glutamatergic function in mood disorders

21 January 2018

1 reference

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults

21 January 2018

1 reference

NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production.

21 January 2018

1 reference

A specific amyloid-beta protein assembly in the brain impairs memory

21 January 2018

1 reference

Brain-derived neurotrophic factor modulates hippocampal synaptic transmission by increasing N-methyl-D-aspartic acid receptor activity

21 January 2018

1 reference

Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study

21 January 2018

1 reference

BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory?

21 January 2018

1 reference

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

21 January 2018

1 reference

The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders

21 January 2018

1 reference

Course of illness, hippocampal function, and hippocampal volume in major depression

21 January 2018

1 reference

Lack of association between prior depressive episodes and cerebral [11C]PiB binding

21 January 2018

1 reference

The cellular neurobiology of depression

21 January 2018

1 reference

Cognitive impairment in major depression

21 January 2018

1 reference

Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder.

21 January 2018

1 reference

Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome.

21 January 2018

1 reference

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

21 January 2018

1 reference

Performance on tests sensitive to impaired executive ability in schizophrenia, mania and well controls: acute and subacute phases.

21 January 2018

1 reference

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease

21 January 2018

1 reference

MRI study of the cerebellum in young bipolar patients

21 January 2018

1 reference

Cerebral white matter lesions in bipolar affective disorder: relationship to outcome

21 January 2018

1 reference

Progressive gray matter loss in patients with bipolar disorder

21 January 2018

1 reference

Ten-year change in plasma amyloid beta levels and late-life cognitive decline

21 January 2018

1 reference

Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction.

21 January 2018

1 reference

Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE

21 January 2018

1 reference

Microglial receptor for advanced glycation end product-dependent signal pathway drives beta-amyloid-induced synaptic depression and long-term depression impairment in entorhinal cortex

21 January 2018

1 reference

Computerized testing of neurocognitive function in euthymic bipolar patients compared to those with mild cognitive impairment and cognitively healthy controls

21 January 2018

1 reference

Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis

21 January 2018

1 reference

Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks

21 January 2018

1 reference

Amyloid beta-peptide Abeta(1-42) but not Abeta(1-40) attenuates synaptic AMPA receptor function

21 January 2018

1 reference

Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments

21 January 2018

1 reference

Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy

21 January 2018

1 reference

Plasma β-amyloid peptides levels: a pilot study in bipolar depressed patients

21 January 2018

1 reference

Elevation in plasma Abeta42 in geriatric depression: a pilot study

21 January 2018

1 reference

Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder

21 January 2018

1 reference

Neurotrophins as synaptic modulators

21 January 2018

1 reference

Modulation of synaptic plasticity by stress and antidepressants

21 January 2018

1 reference

Acute beta-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens

21 January 2018

1 reference

Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models

21 January 2018

1 reference

Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression

21 January 2018

1 reference

Memantine treatment decreases levels of secreted Alzheimer's amyloid precursor protein (APP) and amyloid beta (A beta) peptide in the human neuroblastoma cells

21 January 2018

1 reference

A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder

21 January 2018

1 reference

Depressive symptoms predict incident cognitive impairment in cognitive healthy older women

21 January 2018

1 reference

Depressive symptoms and risk of dementia: the Framingham Heart Study

21 January 2018

1 reference

Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation

21 January 2018

1 reference

Depression, hippocampal volume changes, and cognitive decline in a clinical sample of older depressed outpatients and non-depressed controls

21 January 2018

1 reference

Cerebral changes and cerebrospinal fluid beta-amyloid in Alzheimer's disease: a study with quantitative magnetic resonance imaging

21 January 2018

1 reference

The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease

21 January 2018

1 reference

The ups and downs of Abeta

21 January 2018

1 reference

Bipolar I patients with and without a history of psychotic symptoms: do they differ in their cognitive functioning?

21 January 2018

1 reference

Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications

21 January 2018

1 reference

Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study

21 January 2018

1 reference

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

21 January 2018

1 reference

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

21 January 2018

1 reference

Persistent depressive symptoms and cognitive function in late midlife: the Whitehall II study

21 January 2018

1 reference

Regulation of NMDA receptor trafficking by amyloid-beta

21 January 2018

1 reference

Cross-sectional and longitudinal assessment of structural brain alterations in melancholic depression.

21 January 2018

1 reference

A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease.

21 January 2018

1 reference

The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings

21 January 2018

1 reference

Amyloid-associated depression: a prodromal depression of Alzheimer disease?

21 January 2018

1 reference

RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction

21 January 2018

1 reference

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

Amyloid β peptide oligomers directly activate NMDA receptors.

21 January 2018

1 reference

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

21 January 2018

1 reference

Beta -amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival Is not compromised

21 January 2018

1 reference

Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons.

21 January 2018

1 reference

Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis.

21 January 2018

1 reference

Soluble amyloid beta1-42 reduces dopamine levels in rat prefrontal cortex: relationship to nitric oxide.

21 January 2018

1 reference

beta-Amyloid peptides impair PKC-dependent functions of metabotropic glutamate receptors in prefrontal cortical neurons

21 January 2018

1 reference

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

21 January 2018

1 reference

Silent brain infarcts and the risk of dementia and cognitive decline

21 January 2018

1 reference

A beta oligomers - a decade of discovery

21 January 2018

1 reference

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention.

21 January 2018

1 reference

Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation.

21 January 2018

1 reference

The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging

21 January 2018

1 reference

Presenilins and gamma-secretase inhibitors affect intracellular trafficking and cell surface localization of the gamma-secretase complex components

21 January 2018

1 reference

Learning induces long-term potentiation in the hippocampus

21 January 2018

1 reference

Depressive symptoms, cognitive decline, and risk of AD in older persons.

21 January 2018

1 reference

Verbal memory deficits associated with major affective disorders: a comparison of unipolar and bipolar patients

21 January 2018

1 reference

Plasma antibodies to Abeta40 and Abeta42 in patients with Alzheimer's disease and normal controls.

21 January 2018

1 reference

Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline

21 January 2018

1 reference

Reduced planum temporale volume and delusional behaviour in patients with schizophrenia.

21 January 2018

1 reference

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings

21 January 2018

1 reference

APP processing in Alzheimer's disease

21 January 2018

1 reference

The cerebral beta-amyloid angiopathies: hereditary and sporadic

21 January 2018

1 reference

Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation

21 January 2018

1 reference

Blood-brain barrier transport of circulating Alzheimer's amyloid beta

21 January 2018

1 reference

Cognitive function in euthymic bipolar I disorder

21 January 2018

1 reference

Cerebral White Matter Lesions and Depressive Symptoms in Elderly Adults

21 January 2018

1 reference

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

21 January 2018

1 reference

7 January 2021

Depression and Alzheimer's disease: is stress the initiating factor in a common neuropathological cascade?

1 reference

7 January 2021

Platelets Are the Primary Source of Amyloid β-Peptide in Human Blood

1 reference

7 January 2021

RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier

1 reference

7 January 2021

Is there a CSF biomarker profile related to depression in elderly women?

1 reference

7 January 2021

Dementia in affective disorder: a case-register study

1 reference

7 January 2021

Serum amyloid beta protein in young and elderly depression: a pilot study

1 reference

7 January 2021

Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus

1 reference

7 January 2021

Neurocognitive impairment in bipolar patients with and without history of psychosis.

1 reference

7 January 2021

Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease

1 reference

7 January 2021

Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk

1 reference

7 January 2021

Neuropsychological function in manic-depressive psychosis. Evidence for persistent deficits in patients with chronic, severe illness

1 reference

7 January 2021

MRI analysis of cerebellar vermal abnormalities in bipolar disorder

1 reference

7 January 2021

Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly

1 reference

7 January 2021

Depression, antidepressants, and plasma amyloid beta (Beta) peptides in those elderly who do not have cardiovascular disease

1 reference

7 January 2021

Cognitive impairment, clinical course and treatment history in out-patients with bipolar affective disorder: relationship to tardive dyskinesia

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.3879

1 reference

27 August 2017

1 reference